Gentian Kaloshi

<i>IDH1</i> or <i>IDH2</i> mutations predict longer survival and response to temozolomide in low-grade gliomas

Caroline Houillier, X. Wang, Gentian Kaloshi et al. · Neurology · 2010 · 533 citations

Medicine, Molecular Genetics, Oncology +17

Temozolomide for low-grade gliomas

Gentian Kaloshi, Alexandra Benouaich‐Amiel, Fousseny Diakité et al. · Neurology · 2007 · 283 citations · Full text

Medicine, Oncology, Chemotherapy +13

MGMT methylation: A marker of response to temozolomide in low‐grade gliomas

Sibille Everhard, Gentian Kaloshi, Emmanuelle Crinière et al. · Annals of Neurology · 2006 · 222 citations

Medicine, Neurology, Oncology +15

Dynamic history of low‐grade gliomas before and after temozolomide treatment

Damien Ricard, Gentian Kaloshi, Alexandra Amiel‐Benouaich et al. · Annals of Neurology · 2007 · 203 citations

Medicine, Oncology, Pharmacology +15

A Tumor Growth Inhibition Model for Low-Grade Glioma Treated with Chemotherapy or Radiotherapy

Benjamin Ribba, Gentian Kaloshi, Matthieu Peyre et al. · Clinical Cancer Research · 2012 · 139 citations · Full text

Medicine, Oncology, Pharmacology +16